000755983 000__ 05019cam\a2200421Ii\4500
000755983 001__ 755983
000755983 005__ 20230306141823.0
000755983 006__ m\\\\\o\\d\\\\\\\\
000755983 007__ cr\cn\nnnunnun
000755983 008__ 160621s2016\\\\si\a\\\\o\\\\\001\0\eng\d
000755983 020__ $$a9789812877062$$q(electronic book)
000755983 020__ $$a9812877061$$q(electronic book)
000755983 020__ $$z9789812877055
000755983 0247_ $$a10.1007/978-981-287-706-2$$2doi
000755983 035__ $$aSP(OCoLC)ocn951974919
000755983 035__ $$aSP(OCoLC)951974919
000755983 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dGW5XE$$dYDXCP$$dIDEBK$$dEBLCP$$dAZU$$dOCLCF$$dN$T$$dCOO
000755983 049__ $$aISEA
000755983 050_4 $$aRC840.H38
000755983 08204 $$a616.3/3014$$223
000755983 24500 $$aHelicobacter pylori$$h[electronic resource] /$$cNayoung Kim, editor.
000755983 264_1 $$aSingapore :$$bSpringer,$$c2016.
000755983 300__ $$a1 online resource (x, 556 pages) :$$billustrations.
000755983 336__ $$atext$$btxt$$2rdacontent
000755983 337__ $$acomputer$$bc$$2rdamedia
000755983 338__ $$aonline resource$$bcr$$2rdacarrier
000755983 500__ $$aIncludes index.
000755983 5050_ $$aPart 1. Epidemiology-Prevalence and Transmission routes of H. pylori -- Part 2. Pathophysiology -- 1) Colonization of H. pylori in the stomach -- 2) Brief description of Pathophysiology -- 3) Immune mechanism -- 4) Change of acid secretion, ghrelin and leptin by H. pylori -- 5) H. pylori virulence factors -- A: toxin (CagA, VacA, DupA, OipA, IceA) -- B: genetic polymorphism of toxin and disease -- 6) Host factors: genetic polymorphism, etc -- Part 3. Diagnosis -- 1) Serology -- 2) Histology -- 3) Culture -- 4) UBT -- 5) Stool antigen -- 6) Specific conditions -- A: Children -- B: Bleeding -- Part 4. Symptom -- 1)Symptom of acute and chronic H. pylori infection -- Part 5. Disease -- 1) Atrophic gastritis and Intestinal metaplasia -- 2) Functional dyspepsia -- 3) Peptic ulcer -- 4) MALToma -- 5) Gastric cancer -- A: Synopsis and Epidemiology of gastric cancer -- B1: Pathogenesis: i.Genetic alternation (mutations in tumor-related genes) induced by Activation-induced cytidine deaminase (AID) -- B2: Pathogenesis: ii. Epigenetic mechanisms: aberrant DNA methylation, microRNA -- B3: Pathogenesis:iii. Macrophage inhibitory factor (MIF) -- B4: Pathogenesis: iv. Epidermal mesenchyme transition (EMT) -- B5: Pathogenesis: v. ABO blood type -- B6: Pathogenesis: vi. First relatives of gastric cancer -- C: H. pylori-negative gastric cancer -- 6) Gastroesophageal reflux disease (GERD) -- 7) NSAID-induced gastropathy and H. pylori infection -- 8) Extraintestinal manifestations of H. pylori infection -- A: Iron deficiency anemia -- B: Idiopathic thrombocytopenic purpura -- C: Heart disease -- D: Atopy and allergy -- Part 6. Antibiotic resistance -- 1) Synopsis of antibiotic resistance -- 2) Clarithromycin -- 3) Amoxicillin -- 4) Quinolone -- 5) Metronidazole -- Part 7. Treatment -- 1) Synopsis of antibiotic treatment -- 2) Triple therapy -- 3) Quadruple therapy -- 4) Sequential therapy -- 5) Concomitant therapy -- 6) Tailored therapy based on antibiotic resistance -- 7) Levofloxacin or rifabutin based triple therapy -- 8) Probiotics -- 9) Treatment guidelines -- 10) Screening method of early gastric cancer -- 11) Recrudescence and reinfection -- Part 8. Consequences of H. pylori eradication -- 1) Peptic ulcer disease -- 2) atrophic gastritis and Intestinal metaplasia -- 3) Gastric cancer -- Part 9. The effect of H. pylori on the other microbiota of stomach -- The effect of H. pylori on the other microbiota of stomach -- Part 10. Animal model- H. pylori, H. felis.
000755983 506__ $$aAccess limited to authorized users.
000755983 520__ $$aThis book presents the current state of knowledge regarding the ability of Helicobacter pylori to colonize the gastrointestinal tract, the global epidemiology of H. pylori infection, transmission routes, the pathophysiology of H. pylori-related gastroduodenal and other diseases, diagnosis and treatment methods, guidelines for eradication, antibiotic resistance, the reinfection rate after H. pylori eradication, and animal models of H. pylori or related Helicobacter infection. The aim is to equip readers around the world with the understanding required in order to implement effective methods of H. pylori eradication and to enhance clinical outcomes for patients. The text is clearly written and is complemented by many helpful illustrations. This book will be a great asset in clinical practice for all practitioners who are involved in caring for patients with H. pylori-related diseases or have an interest in the subject. It will also be a useful source of information for medical students and for intelligent laypeople seeking information on H. pylori.
000755983 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed June 23, 2016).
000755983 650_0 $$aHelicobacter pylori infections.
000755983 7001_ $$aKim, Nayoung,$$eeditor.
000755983 77608 $$iPrint version:$$z9789812877055
000755983 852__ $$bebk
000755983 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-981-287-706-2$$zOnline Access$$91397441.1
000755983 909CO $$ooai:library.usi.edu:755983$$pGLOBAL_SET
000755983 980__ $$aEBOOK
000755983 980__ $$aBIB
000755983 982__ $$aEbook
000755983 983__ $$aOnline
000755983 994__ $$a92$$bISE